Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Stephen L Roesch"'
Autor:
Stephen L Roesch, Amanda M Styer, G Craig Wood, Zachary Kosak, Jamie Seiler, Peter Benotti, Anthony T Petrick, Jon Gabrielsen, William E Strodel, Glenn S Gerhard, Christopher D Still, George Argyropoulos
Publikováno v:
PLoS ONE, Vol 10, Iss 2, p e0116928 (2015)
Fibroblast growth factors 19 and 21 (FGF19 and FGF21) have been implicated, independently, in type 2 diabetes (T2D) but it is not known if their circulating levels correlate with each other or whether the associated hepatic signaling mechanisms that
Externí odkaz:
https://doaj.org/article/94093b34952944a89f467b2593ba91be
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e85558 (2014)
BACKGROUND: The enterohepatic pathway involving the fibroblast growth factor 19 (FGF19) and bile acids (BA) has been linked with the etiology and remission of type 2 diabetes (T2D) following Roux-en-Y gastric bypass (RYGB) surgery. Specifically, diab
Externí odkaz:
https://doaj.org/article/4f984707172f4fe4ac8e43dc4faeac1a
Autor:
David D. K. Rolston, David J. Carey, Anthony T. Petrick, A Yavorek, Jon Gabrielsen, Amanda M. Styer, Glenn S. Gerhard, G C Wood, Christopher D. Still, William E. Strodel, Anna Ibele, George Argyropoulos, Stephen L. Roesch, Peter N. Benotti
Publikováno v:
International journal of obesity (2005)
Objective The goal of the present study was to identify differences in gene expression between SAT, VAT, and EAT depots in Class III severely obese individuals. Design Human subcutaneous (SAT) and visceral (VAT) adipose tissues exhibit differential g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae7e4243781528aa127dea4fd9eece3c
http://europepmc.org/articles/PMC3925764
http://europepmc.org/articles/PMC3925764
Autor:
William E. Strodel, Anthony T. Petrick, Glenn S. Gerhard, Stephen L. Roesch, G. Craig Wood, Jon Gabrielsen, Amanda M. Styer, George Argyropoulos, Christopher D. Still
Publikováno v:
Diabetes Care
OBJECTIVE Roux-en-Y gastric bypass (RYGB) in humans can remit type 2 diabetes, but the operative mechanism is not completely understood. In mice, fibroblast growth factor (FGF) 15 (FGF19 in humans) regulates hepatic bile acid (BA) production and can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebf89ac08ba2f31b57aa358a16d64247
https://doi.org/10.2337/dc12-2255
https://doi.org/10.2337/dc12-2255
Autor:
Anthony T. Petrick, William E. Strodel, Jon Gabrielsen, George Argyropoulos, Amanda M. Styer, Zachary Kosak, Christopher D. Still, G. Craig Wood, Jamie Seiler, Stephen L. Roesch, Peter N. Benotti, Glenn S. Gerhard
Publikováno v:
PLoS ONE, Vol 10, Iss 2, p e0116928 (2015)
PLoS ONE
PLoS ONE
Fibroblast growth factors 19 and 21 (FGF19 and FGF21) have been implicated, independently, in type 2 diabetes (T2D) but it is not known if their circulating levels correlate with each other or whether the associated hepatic signaling mechanisms that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92c48a0ac56a8d005a7728a38d06fb47
http://europepmc.org/articles/PMC4321834?pdf=render
http://europepmc.org/articles/PMC4321834?pdf=render
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 1, p e85558 (2014)
PLoS ONE, Vol 9, Iss 1, p e85558 (2014)
Background The enterohepatic pathway involving the fibroblast growth factor 19 (FGF19) and bile acids (BA) has been linked with the etiology and remission of type 2 diabetes (T2D) following Roux-en-Y gastric bypass (RYGB) surgery. Specifically, diabe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10caad276a7e609d0b23a1379be34872
https://doi.org/10.1371/journal.pone.0085558
https://doi.org/10.1371/journal.pone.0085558